Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • specman4 specman4 Jun 6, 2012 1:26 PM Flag

    Vision, Ego, Legacy

    No one likes a reverse split, but it may be a necessary defence. The OR to DE move just adds clarity and makes future deals more agreeable and efficient. The name change may be the real tell in the cards being played.

    I suspect CG did not get to be CEO without a strength for vision and a solid ego. His actions suggest that he believes enough to invest his own cash in their chances at the brass ring. As with all biotechs, the binary event will determine our success. The new name has many possible meanings, but the most applicable come from the bible and relates to a rising from the dead. Phoenix from the ashes, if you will. Something tells me that CG believes this vision can become a reality for AVI/Sarepta. He knows more than we do and is placing big bets on their success. I suspect the 36 week data is in-house and open for evaluation. If this data suggests a real clinical benefit, the brass ring gets closer. If not, they will have to wait on the 48 week data or force a deal to mitigate enterprize risk.

    In poker terms, the stock has a downside risk of about 20-30 cents and an upside gain of $4-$6. Those are great pot odds, if you are getting in the game. If you have been in the game and your average pps is higher... Well, you can only hold or buy more to average down. 10 baggers don't come easy, but they will change your life.

    Good luck to all longs and welcome any new players who like their chances.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
31.76+0.16(+0.51%)Jul 30 4:00 PMEDT